Literature DB >> 21141806

Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.

Daniela Arosio1, Leonardo Manzoni, Elena M V Araldi, Andrea Caprini, Eugenia Monferini, Carlo Scolastico.   

Abstract

The α(v)β(3) integrin is an adhesion molecule involved in physiological and pathological angiogenesis as well as in tumor invasion and metastasis, and therefore, there is a strong interest in developing novel agents interacting with this molecule. We report the synthesis and characterization of fluorescent α(v)β(3) integrin probes and their use to visualize integrin α(v)β(3) expression on human normal and cancer cells. The fluorescent probes we describe here may be of use for noninvasive imaging of α(V)β(3) integrin expression also in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21141806     DOI: 10.1021/bc900155j

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

Review 1.  The Platin-X series: activation, targeting, and delivery.

Authors:  Uttara Basu; Bhabatosh Banik; Ru Wen; Rakesh K Pathak; Shanta Dhar
Journal:  Dalton Trans       Date:  2016-08-16       Impact factor: 4.390

2.  MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.

Authors:  Luca Menichetti; Claudia Kusmic; Daniele Panetta; Daniela Arosio; Debora Petroni; Marco Matteucci; Piero A Salvadori; Cesare Casagrande; Antonio L'Abbate; Leonardo Manzoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-15       Impact factor: 9.236

Review 3.  Click chemistry for the synthesis of RGD-containing integrin ligands.

Authors:  Matteo Colombo; Aldo Bianchi
Journal:  Molecules       Date:  2010-01-06       Impact factor: 4.411

4.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

5.  Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres.

Authors:  Yu-Te Liao; Chia-Hung Liu; Jiashing Yu; Kevin C-W Wu
Journal:  Int J Nanomedicine       Date:  2014-06-05

6.  Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?

Authors:  Dong Luo; Xinning Wang; Sophia Zeng; Gopalakrishnan Ramamurthy; Clemens Burda; James P Basilion
Journal:  Chem Sci       Date:  2019-07-18       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.